Chicago Team Uses Tumor Volume to Predict Mesothelioma Survival, According to Surviving Mesothelioma
Raleigh, NC (PRWEB) January 11, 2016 -- Scientists in Chicago found a close link between the volume of mesothelioma tumors that had been surgically removed and patient survival. Surviving Mesothelioma has just posted an article on the new report. Click here to read it now.
The University of Chicago Medicine team measured the tumor volumes of more than 100 pleural mesothelioma patients who’d had lung-sparing mesothelioma surgery.
After assessing outcomes based on age, gender, histology and the standard TNM staging system, the researchers determined that tumor volume had as much to do with mesothelioma survival as either regional tumor spread or lymph node involvement.
“Tumor volume is an independent predictor of survival in patients with malignant pleural mesothelioma undergoing EPD...and is complimentary to TNM staging,” concludes study author Diana Kircheva in the Journal of Cardiothoracic Surgery.
“This study is significant because cancer staging is about more than just predicting mesothelioma outcomes. It is also a vital part of treatment planning,” says Surviving Mesothelioma’s Managing Editor, Alex Strauss.
Find out more about mesothelioma staging and how this new data may affect it in Tumor Volume Helps Predict Mesothelioma Survival, now available on the Surviving Mesothelioma website.
Kircheva, D, et al, Tumor volume is an independent predictor of survival in patients with malignant pleural mesothelioma, December 18, 2015, Journal of Cardiothoracic Surgery, Epub ahead of print, http://www.cardiothoracicsurgery.org/content/pdf/1749-8090-10-S1-A48.pdf
For nearly ten years, Surviving Mesothelioma has brought readers the most important and ground-breaking news on the causes, diagnosis and treatment of mesothelioma. All Surviving Mesothelioma news is gathered and reported directly from the peer-reviewed medical literature. Written for patients and their loved ones, Surviving Mesothelioma news helps families make more informed decisions.
Michael Ellis, Cancer Monthy, http://www.survivingmesothelioma.com, +1 (919) 570-8595, [email protected]
Share this article